Literature DB >> 22941204

Cloning of the human activated leukocyte cell adhesion molecule promoter and identification of its tissue-independent transcriptional activation by Sp1.

Fang Tan1, Flaubert Mbunkui, Solomon F Ofori-Acquah.   

Abstract

Activated leukocyte cell adhesion molecule (ALCAM) belongs to the immunoglobulin cell adhesion molecule super family. ALCAM is implicated in tumor progression, inflammation, and the differentiation of hematopoietic stem cells. Hitherto, the identity of regulatory DNA elements and cognate transcription factors responsible for ALCAM gene expression remained unknown. In this report, the human ALCAM promoter was cloned and its transcriptional mechanisms elucidated. The promoter is TATA-less and contains multiple GC-boxes. A proximal 650-bp promoter fragment conferred tissue-independent activation, whereas two contiguous regions upstream of this region negatively influenced promoter activity in a tissue-specific manner. The positive regulatory promoter region was mapped to a core 50 base pair sequence containing a conical Sp1 element. Mutation analysis revealed that this element alone or in tandem with elements immediately upstream was required for maximal promoter activity. Chromatin analysis revealed that Sp1 binds exclusively to the canonical binding sequence in vivo, but not to DNA sequence immediately upstream. Finally, we showed that over-expression of Sp1 significantly increased the basal promoter activity. Thus, Sp1 activated the ALCAM promoter in most cells. These findings have important ramifications for unraveling the roles of ALCAM in inflammation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941204      PMCID: PMC3683579          DOI: 10.2478/s11658-012-0028-1

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  45 in total

1.  Relevance of CD6-mediated interactions in T cell activation and proliferation.

Authors:  Idoia Gimferrer; Maria Calvo; María Mittelbrunn; Montse Farnós; Maria Rosa Sarrias; Carlos Enrich; Jordi Vives; Francisco Sánchez-Madrid; Francisco Lozano
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

2.  Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.

Authors:  Namir J Hassan; A Neil Barclay; Marion H Brown
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

3.  Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin.

Authors:  L C van Kempen; J J van den Oord; G N van Muijen; U H Weidle; H P Bloemers; G W Swart
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.

Authors:  Glen Kristiansen; Christian Pilarsky; Christoph Wissmann; Carsten Stephan; Lothar Weissbach; Volker Loy; Stefan Loening; Manfred Dietel; André Rosenthal
Journal:  Prostate       Date:  2003-01-01       Impact factor: 4.104

5.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis.

Authors:  A B Al-Mehdi; K Tozawa; A B Fisher; L Shientag; A Lee; R J Muschel
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

6.  Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166).

Authors:  Hiroshi Fujiwara; Keiji Tatsumi; Kenzo Kosaka; Yukiyasu Sato; Toshihiro Higuchi; Shinya Yoshioka; Michiyuki Maeda; Masamichi Ueda; Shingo Fujii
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  [Expression and significance of activated leukocyte cell adhesion molecule in prostatic intraepithelial neoplasia and adenocarcinoma].

Authors:  Xiangyi Zheng; Wei Ding; Liping Xie; Zhaodian Chen
Journal:  Zhonghua Nan Ke Xue       Date:  2004-04

Review 8.  Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration.

Authors:  Guido W M Swart
Journal:  Eur J Cell Biol       Date:  2002-06       Impact factor: 4.492

9.  Intravascular location of breast cancer cells after spontaneous metastasis to the lung.

Authors:  Christopher W Wong; Chun Song; Maggie M Grimes; Weili Fu; Mark W Dewhirst; Ruth J Muschel; Abu-Bakr Al-Mehdi
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  Essential role for ALCAM gene silencing in megakaryocytic differentiation of K562 cells.

Authors:  Fang Tan; Samit Ghosh; Flaubert Mbeunkui; Robert Thomas; Joshua A Weiner; Solomon F Ofori-Acquah
Journal:  BMC Mol Biol       Date:  2010-12-02       Impact factor: 2.946

View more
  3 in total

Review 1.  Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.

Authors:  Ariana von Lersner; Lenny Droesen; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2019-02-18       Impact factor: 5.150

2.  Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.

Authors:  Fang Tan; Marina Mosunjac; Amy L Adams; Beverly Adade; Oleyad Taye; Yijuan Hu; Monica Rizzo; Solomon F Ofori-Acquah
Journal:  BMC Cancer       Date:  2014-09-25       Impact factor: 4.430

3.  Insight into the molecular mechanism of miR-192 regulating Escherichia coli resistance in piglets.

Authors:  Li Sun; Sen Wu; Chao-Hui Dai; Shou-Yong Sun; Guo-Qiang Zhu; Sheng-Long Wu; Wen-Bin Bao
Journal:  Biosci Rep       Date:  2018-02-21       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.